You are now leaving a Radius Health controlled website. Radius Health does not endorse and is not responsible for the accuracy, content, practices, procedures or standards of any non-Radius Health websites.
Full-Year 2019 TYMLOS U.S. net revenue exceeds financial guidance, surpassing $172M . TYMLOS exits 2019 with 52% market share in new patients 1 , on track for market leadership in 2020. Radius delivers strong year-end balance sheet with $160M cash 2 balance and expects to achieve profitability
WALTHAM, Mass. , Jan. 06, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that its senior executive management team will present a corporate update at the 38 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020 at 11:30 am PST at the Westin St.
WALTHAM, Mass. , Dec. 06, 2019 (GLOBE NEWSWIRE) -- Radius Health , Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) today announced its scientific presentations on elacestrant and RAD140 at the upcoming 2019 San Antonio Breast Cancer Symposium, which will take place from December 10 – 14 in San
WALTHAM, Mass. , Dec. 02, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq:RDUS) today announced that the Compensation Committee of the Company’s Board of Directors granted a new employee an option to purchase 50,000 shares of the Company’s common stock with a per
WALTHAM, Mass. , Nov. 15, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that Jesper Hoeiland, President and CEO of the Company, will present a corporate update at the Jefferies 2019 Global Healthcare Conference in London, United Kingdom on Wednesday, November 20, 2019
TYMLOS U.S. net sales grew to $47M and is capturing half of anabolic new patient starts 1 Guidance for FY 2019 sales increased to $168-$172M (vs. $165-$170M prior) and year-end cash, cash equivalents and investments balance increased to over $130M (vs.
WALTHAM, Mass. , Oct. 23, 2019 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its third quarter 2019 financial results on Tuesday, November 5, 2019 . The Company will host a conference call and live audio webcast at 4:30 p.m.
WALTHAM, Mass. , Sept. 13, 2019 (GLOBE NEWSWIRE) -- Radius Health , Inc. (Nasdaq: RDUS), today announced it will present five posters, including results from a real-world study on patient experience, at the American Society for Bone and Mineral Research (ASBMR) 2019 Annual Meeting, which will take
WALTHAM, Mass. , Sept. 03, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS) today announced its participation in the following conferences in September 2019 . Radius Health management will host meetings with investors at the Citi 14 th Annual Biotech Conference in Boston on September 5,
TYMLOS® U.S. net sales were $41.0 million in the second quarter of 201 9, an 81% growth over the second quarter of 2018. TYMLOS continued increasing its share of the U.S. anabolic osteoporosis market capturing an average of 35% total market share and 46% share in new patients in the second quarter